Table 1.
Demographic data and clinical characteristics of the study population.
| Demographic data, clinical characteristics and assessments Mean ± SD, n (%) or median (Q1-Q3) | Overall (n = 66) | Day 10 (n = 46) | Week 4 (n = 46) | Month 3 (n = 51) | Month 6 (n = 50) | Month 12 (n = 48) |
|---|---|---|---|---|---|---|
| Age | 65.7 ± 13.4 | 64.02 ± 13.89 | 64.62 ± 12.08 | 64.44 ± 12.81 | 65.10 ± 13.36 | 64.67 ± 12.29 |
| Female | 27 (41%) | 16 (35%) | 19 (41%) | 22 (43%) | 22 (44%) | 20 (42%) |
| Ischemic/Haemorrhagic stroke (%) | 81/19 | 83/17 | 78/22 | 74/26 | 76/24 | 75/25 |
| Right hand dominant | 63 (95%) | 44 (96%) | 44 (96%) | 49 (96%) | 48 (96%) | 46 (96%) |
| Right hemiparesis | 29 (44%) | 20 (44%) | 19 (41%) | 22 (43%) | 22 (43%) | 19 (40%) |
| Inpatient rehabilitation | — | 27 (58%) | 1 (2%) | none | none | none |
| FMA-UE score | — | 61 (56–64) | 64 (60–66) | 64 (61–66) | 64 (60–66) | 64 (61–66) |
| Score <9 in BNI pre-screening | — | 4 (9%) | 2 (4%) | 4 (8%) | 4 (8%) | 1 (2%) |
| ABILHAND logits | — | 2.44 ± 1.95 | 3.84 ± 1.94 | 4.35 ± 1.69 | 4.30 ± 1.91 | 4.66 ± 1.62 |
| ABILHAND standard error | — | 1.20 ± 0.49 | 1.31 ± 0.91 | 1.20 ± 0.52 | 1.17 ± 0.53 | 1.24 ± 0.54 |
| Movement time (s) | — | 2.06 ± 0.95 | 1.70 ± 0.65 | 1.72 ± 0.78 | 1.61 ± 0.60 | 1.62 ± 0.63 |
| Mean velocity (m/s) | — | 0.17 ± 0.05 | 0.19 ± 0.06 | 0.19 ± 0.06 | 0.19 ± 0.06 | 0.20 ± 0.07 |
| Peak velocity (m/s) | — | 0.41 ± 0.12 | 0.42 ± 0.12 | 0.43 ± 0.13 | 0.43 ± 0.12 | 0.44 ± 0.14 |
| Number of velocity peaks (n) | — | 3.99 ± 1.72 | 3.43 ± 1.54 | 3.41 ± 1.25 | 3.24 ± 0.97 | 3.33 ± 1.07 |
Abbreviations: SD, Standard deviation; Q1–Q3, Quartiles; FMA, Fugl-Meyer Assessment of Sensorimotor Function, ARAT, Action Research Arm Test, BNI, Barrow Neurological Institute.